Dr Reddy's gets nod for amalgamation of Dr Reddy's Holdings into company

21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added

Dr Reddy's
Shares of Dr Reddy's Laboratories on Friday settled at Rs 2,888.90 on the BSE, up 0.87 per cent from its previous close.
Press Trust of India New Delhi
2 min read Last Updated : Jan 03 2020 | 6:38 PM IST

Drug major Dr Reddy's Laboratories on Friday said it has received shareholders nod for proposed amalgamation of Dr Reddy's Holdings Ltd into the company.

The resolution for the scheme was approved by 99.98 per cent votes of the total 13.10 crore votes casted by equity shareholders of the company, it said in a regulatory filing.

21,026 votes, which accounted for the rest 0.02 per cent, were posted against the resolution, it added.

The voting was conducted as per the directions of the Hyderabad Bench of the National Company Law Tribunal on November 22, 2019.

The meeting of equity shareholders was convened on January 2, 2020.

The board of Dr Reddy's Laboratories had on July 29, 2019, approved the amalgamation of Dr Reddy's Holdings Ltd, an entity held by the promoter group which holds 24.88 per cent equity shares of Dr Reddy's Laboratories, into the company.

The scheme would lead to simplification of the shareholding structure and reduction of shareholding tiers, the company had said.

"The Promoter Group cumulatively will continue to hold the same number of shares in the Company, pre and post the amalgamation," it had said.

Shares of Dr Reddy's Laboratories on Friday settled at Rs 2,888.90 on the BSE, up 0.87 per cent from its previous close.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Dr Reddy's LaboratoriesDr Reddy's Laboratories Limitedmerger

First Published: Jan 03 2020 | 5:45 PM IST

Next Story